Ensysce Biosciences's total assets for Q2 2025 were $5.57M, an increase of 20.87% from the previous quarter. ENSC total liabilities were $2.51M for the fiscal quarter, a 32.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.